RespireRx enters $100K demand note with director Nasiek; warrant for 33.3M shares

RespireRx Pharmaceuticals Inc.

$100,000 demand promissory note issued to Dariusz Nasiek and Sara Nasiek JTTEN; 10% interest payable on demand.
Warrant to purchase 33,333,333 shares of common stock at $0.0015/share, exercisable for 5 years.
Proceeds used for working capital, R&D, and general corporate purposes.
Dariusz Nasiek is a Board member; transaction is a related-party arrangement.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

RespireRx Pharmaceuticals Inc. entered into Purchase Agreement with Dariusz Nasiek and Sara Nasiek, JTTEN valued at $100,000.00 (effective 2024-04-10).

Action: entry
Agreement: equity purchase
Counterparty: Dariusz Nasiek and Sara Nasiek, JTTEN
Value: $100,000.00
Effective: 2024-04-10

Exact text from the filing

On April 10, 2024, the RespireRx Pharmaceuticals Inc. (“RespireRx” or the “Company”) entered into a Demand Promissory Note and Warrant Agreement (“Purchase Agreement”)

View on SEC.gov

419 material agreements filed in the last 30 days. Browse all material agreements →

Source: SEC EDGAR

accession 0001493152-24-014816

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.